Recall of Immulite 2500 insulin Kit

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by Diagnostic Products Corp.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Event ID
  • Event Risk Class
    Class 3
  • Event Number
  • Event Initiated Date
  • Event Date Posted
  • Event Status
  • Event Country
  • Event Terminated Date
  • Event Source
  • Event Source URL
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    Radioimmunoassay, Immunoreactive Insulin - Product Code CFP
  • Reason
    Low bias of 10 to 40% at different levels of insulin in samples.
  • Action
    Customers were notified by telephone on 11/19/2004. They were instructed to discard remaining kits.



  • Manufacturer Address
    Diagnostic Products Corp, 5210 Pacific Concourse Dr, Los Angeles CA 90045-6900
  • Source